HLN — Haleon plc
Healthcare • Drug Manufacturers - Specialty & Generic
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company...…
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $9.85
- Day High
- $9.91
- Day Low
- $9.81
- 52w High
- $11.42
- 52w Low
- $8.71
- Volume
- 11,191,506
- Avg Volume
- Beta
- 0.227
* TTM/most recent where available
Company
- Ticker
- HLN
- Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- GB
- CEO
- Brian James McNamara
- Employees
- 24561
- Website
- www.haleon.com
Key Metrics
- Market Cap
- 44.5B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).